CD68 Antibody

What is CD68 and why is it a critical marker in immunological research?

CD68 is a 110 kDa glycoprotein (reported as 37.4 kDa in its canonical form) belonging to the lysosomal-associated membrane protein (LAMP) family and scavenger receptor family. In humans, the protein consists of 354 amino acid residues with up to three different isoforms reported . CD68 is primarily localized in lysosomes and cell membranes, with a smaller fraction circulating to the cell surface.

CD68's importance in research stems from its role in:

• Phagocytic activities of tissue macrophages

• Intracellular lysosomal metabolism

• Extracellular cell-cell and cell-pathogen interactions

• Binding to tissue- and organ-specific lectins or selectins

• Enabling macrophage mobility over selectin-bearing substrates

CD68 undergoes post-translational modifications, particularly O-glycosylation, which affects its function and detection . The protein serves as a key marker for identifying macrophages and related cells in both normal and disease states.

Primary CD68-expressing cells:

• Monocytes and macrophages

• Kupffer cells (liver macrophages)

• Microglia (brain macrophages)

• Hofbauer cells (placental macrophages)

• Uterine macrophages

• Large intestine macrophages

• Dendritic cells

• Peripheral blood granulocytes

Other cells with reported CD68 expression:

• Hematopoietic progenitors

• γ/δ T cells

• NK cells

• LAK cells

• Subset of B cells

• Fibroblasts

• Endothelial cells

While widely used as a pan-macrophage marker, CD68 is not exclusively expressed by macrophages. Research has shown expression in non-myeloid cells including tumor stroma such as fibroblasts and endothelial cells . Therefore, using CD68 in combination with other markers is recommended for definitive macrophage identification, especially in complex tissue environments.

CD68 is predominantly expressed intracellularly, requiring specific protocols for effective detection by flow cytometry:

Fixation and permeabilization:

• Fix cells with 4% paraformaldehyde diluted in PBS for 20 minutes on ice

• Wash twice with FACS buffer (PBS+2% FCS, 1mM EDTA, 0.1% sodium azide)

• Permeabilize with 0.5% saponin in FACS buffer for 30 minutes on ice

• Wash cells twice with FACS buffer

Staining recommendations:

• Use 5 μl of antibody per million cells in 100 μl staining volume or 5 μl per 100 μl of whole blood

• Block Fc receptors before staining (e.g., Mouse Seroblock for mouse samples)

• Include appropriate isotype controls at the same concentration as the CD68 antibody

• For multicolor panels, include fluorescence minus one (FMO) controls

• Maintain permeabilization reagent in all wash buffers when using saponin-based protocols

Researchers report best results when using commercial permeabilization buffers like Leucoperm™ for intracellular CD68 staining, as demonstrated in multiple validated protocols .

What strategies can help distinguish macrophage subpopulations using CD68?

While CD68 alone cannot differentiate macrophage subsets, strategic combinations with other markers enable identification of functionally distinct populations:

Dual staining approaches:

• CD68 (MCA341A488) and CD163 (MCA342A647) can distinguish CD163-low M1-like macrophages from CD163-high M2-like macrophages in rat samples

• CD68 (MCA1957A488) and CD88 (MCA2456A647) combination works effectively for mouse peritoneal macrophages

• CD68 (MCA5709F) and CD11b (MCA551A647) for human peripheral blood monocytes

Polarization analysis:

For comprehensive macrophage polarization studies, combine CD68 with:

• M1 markers: CD80, CD86, MHC-II (high expression)

• M2 markers: CD163, CD206

• Additional functional markers based on research context

Flow cytometry dot plots from one study showed distinct CD68-positive populations with differential expression of CD163, allowing clear discrimination between macrophage phenotypes .

How do different tissue preparation methods affect CD68 antibody performance?

Tissue preparation significantly impacts CD68 antibody binding and detection sensitivity:

For frozen sections:

• Generally preserves epitope integrity better than FFPE

• Example protocol: Rat anti-mouse CD68 (MCA1957) used at 1/100 dilution followed by goat anti-rat IgG:HRP (STAR72) at 1/50 dilution shows excellent results on frozen mouse lymph node sections

• Requires shorter fixation times (typically acetone or 4% paraformaldehyde)

For paraffin-embedded tissues (FFPE):

• Requires heat-mediated antigen retrieval with citrate buffer (pH 6.0)

• Some clones (e.g., FA-11) are not recommended for FFPE tissues

• Extended retrieval times may be needed for heavily fixed or archival samples

• Clone KP1 is frequently used and validated for FFPE human tissues

For challenging tissues (bone, brain, fibrotic samples):

• Extended decalcification can affect epitope integrity in bone samples

• High lipid content in brain tissue may affect permeabilization

• Fibrotic tissues may require extended antigen retrieval

Researchers report that CD68 staining in IHC of paraffin sections consistently requires heat-mediated antigen retrieval prior to staining, with citrate buffer (pH 6.0) recommended for optimal results .

What troubleshooting approaches are effective for CD68 antibody specificity issues?

When experiencing specificity issues with CD68 antibodies, consider these validated troubleshooting strategies:

For background staining:

• Increase blocking time using serum from the same species as the secondary antibody

• Add 0.1-0.3% Triton X-100 to blocking buffer to reduce hydrophobic interactions

• Use specific Fc receptor blocking reagents, especially important for myeloid cells

• Ensure proper permeabilization when targeting intracellular CD68

For multiple bands in Western blot:

• CD68 is heavily glycosylated; multiple bands may represent different glycoforms

• A positive control for CD68 should be run when using antibodies for Western blotting

• Some researchers report observing a 110 kDa band rather than the predicted 37 kDa size due to glycosylation

For cross-reactivity issues:

• Verify species specificity of your antibody clone

• Use knockout/knockdown controls when available

• Test the antibody on known negative cells/tissues

• Consider using multiple CD68 antibody clones targeting different epitopes

Researchers noted that different clones may detect different glycosylation forms of CD68, which can affect experimental reproducibility .

How does CD68 expression change in disease states and what are the implications for research?

CD68 expression patterns vary in different disease contexts, providing valuable insights for researchers:

In inflammatory conditions:

• CD68 expression is upregulated by proinflammatory stimuli

• Glycosylation patterns can change with macrophage activation state

• Increased surface translocation from intracellular pools occurs during inflammation

In cancer research:

• CD68 has been detected in tumor stroma including fibroblasts and endothelial cells

• CD68+ cells in tumor microenvironments may represent tumor-associated macrophages

• Elevated expression on CD34+ cells has been demonstrated in various human malignancies, including several acute myeloid leukemia studies

In neurodegenerative diseases:

• Used to assess microglial activation and neuroinflammation

• Often combined with other microglial markers like Iba1

Interpretation should consider both the presence of CD68+ cells and their functional state, as the marker alone doesn't indicate macrophage polarization or activity.

What are best practices for quantitative analysis of CD68 immunostaining?

For rigorous quantitative analysis of CD68 immunostaining, follow these methodological approaches:

For flow cytometry:

• Set quadrant gates so that >99% of events are negative when stained with matched isotype controls

• For analysis of mixed populations, use co-staining to distinguish macrophages from other CD68+ cells

• Report percentage of positive cells and mean fluorescence intensity

For tissue section analysis:

• Use standardized staining protocols with consistent antibody concentrations

• Include positive and negative control tissues in each batch

• Select between whole slide scanning or representative fields based on research question

• Consider both cell numbers (CD68+ cells per mm² or per high-power field) and staining intensity

• Employ digital image analysis for consistent quantification across samples

For Western blot quantification:

• Account for potential multiple bands representing different glycoforms

• Use appropriate positive controls (e.g., human spleen tissue lysate)

• Normalize to appropriate loading controls

Proper quantification is essential for comparative studies and should be reported with details about the analytical methods employed.

How can CD68 antibodies be integrated into multiparameter analysis frameworks?

Modern research often requires integration of CD68 into complex, multiparameter analyses:

For multicolor flow cytometry:

• Choose fluorophores that minimize spectral overlap

• For pre-conjugated CD68 antibodies, options include PE, FITC, Alexa Fluor dyes, and tandem dyes like PE-Cy7

• When using dual-laser cytometers with PE-Cy7 conjugates, employ cross-beam compensation during data acquisition or software compensation during analysis

• For human samples, validated combinations include CD68 with CD11b for monocyte analysis

For multiplex immunohistochemistry:

• Use automated multiplex platforms or sequential staining approaches

• Consider tyramide signal amplification for weak signals

• Employ spectral unmixing for fluorescent multiplex approaches

• CD68 works effectively in combination with lineage and functional markers

For transcriptional and protein correlation:

• Integrate single-cell approaches combining CD68 protein detection with transcriptional profiling

• Consider bulk RNA-seq of sorted CD68+ populations to establish functional correlates

These integrated approaches allow researchers to place CD68+ cells in broader biological contexts and understand their functional heterogeneity.